Oxford Brain Diagnostics Ltd is rethinking how brain health is assessed and managed. Founded in neuropathological and neuroimaging expertise, the company’s patented Cortical Disarray Measurement (CDM®) technology uses MRI brain scan data to support early and differential diagnosis, track progression, and predict the decline of neurodegenerative diseases. Oxford Brain Diagnostics is committed to assessing brain health based on changes in the cellular structure, supporting drug development, and helping clinicians around the world in their fight to defeat Alzheimer’s and other neurodegenerative diseases.


Health Data

Life Sciences

Medical Devices

Oxford Brain Diagnostics Ltd

Steven Chance

Daniel Kaute

Nao Kamiya

Terry Pollard

Omar Ehsan

Ian Hardingham

Ged Ridgway

Leadership Team

Engineering and Science

Teams at Oxford Brain Diagnostics Ltd

Leadership Team

Engineering and Science